Citigroup and Evercore ISI are acting as book-running managers for the proposed IPO and as representatives of the underwriters. RBC Capital Markets and William Blair are acting as joint bookrunners, ...

Smithfield Foods could be one of the year's biggest U.S. initial public offerings, with the pork producer planning to raise as much as $940 million as it returns to the stock market.

The funds will support the development of Ascentage’s pipeline, including its lead candidate olverembatinib to treat blood ...

In 2024, global and US markets saw a slight increase in IPOs. Syntax Data used its FIS classification system to analyze the ...

The tepid reception to Venture Global's ambitious valuation target shows companies need to set realistic expectations when ...

After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...

Some of the most high-profile names that are likely to headline this year's IPO market resurgence include Swedish payments ...

US pork processor Smithfield Foods is seeking to raise as much as about $940m in an initial public offering on the New York ...

Ascentage Pharma said on Tuesday it was targeting a valuation of $1.75 billion in its initial public offering, becoming the first sizeable Chinese firm to pursue a listing in the U.S. this year.

Smithfield, owned by China's WH Group, on Tuesday said it plans to sell 17.4 million shares at between $23 and $27 apiece in the IPO. At the $25 midpoint of that range, the Smithfield, Va., company ...